Work

Rapid Diagnostic Tests for Meningitis and Encephalitis—BioFire

Year: 2020

Type: review

Abstract: Meningitis and encephalitis (ME) are important causes of morbidity and mortality worldwide. Patients suspected of having ME are often hospitalized and started on empiric antimicrobial treatment, because of the potential adverse consequences of delaying the diagnosis or treatment. Multiplexed polymerase chain reaction panels are one of several rapid diagnostic technologies that have the potential to overcome some of the limitations of conventional diagnostic methods for ME. The BioFire FilmArray Meningitis/Encephalitis Panel was the first Food and Drug Administration-cleared multiplex polymerase chain reaction for the evaluation of cerebrospinal fluid samples, able to identify 14 organisms in a single test reaction. This newer rapid diagnostic tool has an overall high sensitivity and specificity for the diagnosis of ME with a fast turnaround time and has the potential to improve resource utilization for patients presenting with suspicion of ME. However, further research is needed to determine its optimal use in the evaluation of patients with suspected ME.

Source: Pediatric Emergency Care

DOI: 10.1097/pec.0000000000002180

Authors: Eduardo Fleischer, Paul L. Aronson

Institution: Yale University

Language: English

Topic: Bacterial Identification and Susceptibility Testing

Subfield: Microbiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Agency for Healthcare Research and Quality, National Center for Advancing Translational Sciences